577
Views
3
CrossRef citations to date
0
Altmetric
Review articles

Current status and future direction of duck hepatitis A virus vaccines

, , &
Pages 89-99 | Received 09 Oct 2022, Accepted 20 Dec 2022, Published online: 19 Jan 2023

References

  • Asplin, F.D. (1965). Duck hepatitis. The Veterinary Record, 77, 487–488.
  • Cao, J., Zhang, Y., Chen, Y., Liang, S., Liu, D., Fan, W., Xu, Y., Zhou, Z., & Hou, S. (2020). Dynamic transcriptome reveals the mechanism of liver injury caused by DHAV-3 infection in Pekin duck. Frontiers in Immunology, 11, 568565.
  • Chen, J., Zhang, R., Lan, J., Lin, S., Li, P., Gao, J., Wang, Y., Xie, Z.-J., Jiang, S.-J. (2019). IGF2BP1 significantly enhances translation efficiency of duck hepatitis A virus type 1 without affecting viral replication. Biomolecules, 9, 594.
  • Chen, J.H., Zhang, R.H., Lin, S.L., Li, P.F., Lan, J.J., Song, S.S., Gao, J.-M., Wang, Y., Xie, Z.-J. & Jiang, S.-J. (2018). The functional role of the 3’ untranslated region and poly(A) tail of duck hepatitis A virus type 1 in viral replication and regulation of IRES-mediated translation. Frontiers in Microbiology, 9, 2250.
  • Chen, Z., Shi, S.H., Huang, Y., Huang, C.Q., Liu, R.C., Cheng, L.F., Fu, G.H., Wan, C.H. & Fu, Q.L. (2021). Differential metabolism-associated gene expression of duck pancreatic cells in response to two strains of duck hepatitis A virus type 1. Archives of Virology, 166, 3105–3116.
  • Doan, H.T., Le, X.T., Do, R.T., Hoang, C.T., Nguyen, K.T. & Le, T.H. (2016). Molecular genotyping of duck hepatitis A viruses (DHAV) in Vietnam. The Journal of Infection in Developing Countries, 10, 988–995.
  • Fehér, E., Jakab, S., Bali, K., Kaszab, E., Nagy, B., Ihász, K., Bálint, Á, Palya, V. & Bányai, K. (2021). Genomic epidemiology and evolution of duck hepatitis A virus. Viruses, 13, 1592.
  • Fu, G., Huang, Y., Fu, Q., Cheng, L., Wan, C. & Shi, S. (2014). Molecular characteristic of duck hepatitis A virus type 1 causing pancreatitis. Acta Microbiologica Sinica, 54, 1082–1089.
  • Fu, Y., Chen, Z., Li, C. & Liu, G. (2012). Establishment of a duck cell line susceptible to duck hepatitis virus type 1. Journal of Virological Methods, 184, 41–45.
  • Fu, Y., Pan, M., Wang, X.Y., Xu, Y.L., Yang, H.C. & Zhang, D.B. (2008). Molecular detection and typing of duck hepatitis A virus directly from clinical specimens. Veterinary Microbiology, 131, 247–257.
  • Gough, R.E., Collins, M.S., Borland, E. & Keymer, L.F. (1984). Astrovirus-like particles associated with hepatitis in ducklings. The Veterinary Record, 114, 279.
  • Gough, R.E. & Spackman, D. (1981). Studies with inactivated duck virus hepatitis vaccines in breeder ducks. Avian Pathology, 10, 471–479.
  • Guo, Y. & Pan, W. (1984). Preliminary identifications of the duck hepatitis virus serotypes isolated in Beijing. China. Chinese Journal of Veterinary Medicine, 10, 2–3.
  • Hanson, L.E. & Tripathy, D.N. (1976). Oral immunization of ducklings with attenuated duck hepatitis virus. Developments in Biological Standardization, 33, 357–363.
  • Hassan, T.I.R., Eid, A.A.M., Ghanem, I.A.I., Shahin, A.M., Adael, S.A.A. & Mohamed, F.F. (2020). First report of duck hepatitis A virus 3 from duckling flocks of Egypt. Avian Diseases, 64, 269–276.
  • Kang, M., Roh, J.H. & Jang, H.K. (2018). Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings. Veterinary Microbiology, 214, 108–112.
  • Kang, M.S., Jang, H., Kim, M.C., Kim, M.J., Joh, S.J., Kwon, J.H. & Kwon, Y.K. (2010). Development of a stabilizer for lyophilization of an attenuated duck viral hepatitis vaccine. Poultry Science, 89, 1167–1170.
  • Kim, M.C., Kim, M.J., Kwon, Y.K., Lindberg, A.M., Joh, S.J., Kwon, H.M. & Lee, Y.-J. (2009). Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections. Vaccine, 27, 6688–6694.
  • Kim, M.C., Kwon, Y.K., Joh, S.J., Kwon, J.H., Kim, J.H. & Kim, S.J. (2007). Development of one-step reverse transcriptase-polymerase chain reaction to detect duck hepatitis virus type 1. Avian Diseases, 51, 540–545.
  • Ku, Z., Ye, X., Huang, X., Cai, Y., Liu, Q., Li, Y., & Su, Z. (2013). Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PloS One, 8, e57601.
  • Lai, Y., Xia, X., Cheng, A., Wang, M., Ou, X., Mao, S., Sun, D., Zhang, S., Yang, Q., Wu, Y., Zhu, D., Jia, R., Chen, S., Liu, M., Zhao, X.-X., Huang, J., Gao, Q., Tian, B., Liu, Y., Yu, Y., Zhang, L. & Pan, L. (2021). DHAV-1 blocks the signaling pathway upstream of type I interferon by inhibiting the interferon regulatory factor 7 protein. Frontiers in Microbiology, 12, 700434.
  • Levine, P.P. & Fabricant, J. (1950). A hitherto-undescribed virus disease of ducks in North America. Cornell Veterinarian, 40, 71–86.
  • Levine, P.P. & Hofstad, M.S. (1945). Duck disease investigation. Annual Report of the New York State Veterinary College, Ithaca, NY, pp. 55–56.
  • Li, X., Tang, X., Wang, M., Cheng, A., Ou, X., Mao, S., Sun, D., Yang, Q., Wu, Y., Zhang, S., Zhu, D., Jia, R., Chen, S., Liu, M., Zhao, X., Huang, J., Gao, Q., Tian, B., Liu, Y., Yu, Y., Zhang, L. & Pan, L. (2022). The lysine at position 151 of the duck hepatitis A virus 1 2C protein is critical for its NTPase activities. Veterinary Microbiology, 264, 109300.
  • Li, X., Zhao, R., Lin, W., Li, C., Zhang, T., Meng, F. & Liu, M. (2017). Evidence of VP1 of duck hepatitis A type 1 virus as a target of neutralizing antibodies and involving receptor-binding activity. Virus Research, 227, 240–244.
  • Liang, S., Tang, J., Wang, X., Wen, Z., Xie, M., Wu, Y., Hou, S. & Zhang, D. (2020). Effect of duck hepatitis A virus genotype 3 infection on glucose metabolism of Pekin ducklings and underlying mechanism. Gene, 748, 144710.
  • Liang, S., Xie, M., Tang, J., Wang, M., Zhang, D. & Hou, S. (2020). Proteomics reveals the effect of type I interferon on the pathogenicity of duck hepatitis A virus genotype 3 in Pekin ducks. Veterinary Microbiology, 248, 108813.
  • Lin, S.L., Cong, R.C., Zhang, R.H., Chen, J.H., Xia, L.L., Xie, Z.J., Wang, Y., Zhu, Y.-L. & Jiang, S.-J. (2016). Circulation and in vivo distribution of duck hepatitis A virus types 1 and 3 in infected ducklings. Archives of Virology, 161, 405–416.
  • Liu, G., Wang, F., Ni, Z., Yun, T., Yu, B., Huang, J., & Chen, J. (2008). Genetic diversity of the VP1 gene of duck hepatitis virus type I (DHV-I) isolates from southeast China is related to isolate attenuation. Virus Research, 137, 137–141.
  • Liu, M., Fanyi, M., Li, X.J., Zhang, Z., Liu, S. & Zhang, Y. (2011). Goose haemorrhagic hepatitis caused by a new subtype duck hepatitis type 1 virus. Veterinary Microbiology, 152, 280–283.
  • Liu, R., Shi, S., Huang, Y., Chen, Z., Chen, C., Cheng, L., Fu, G., Wan, C. & Fu, Q. (2019). Comparative pathogenicity of different subtypes of duck hepatitis A virus in Pekin ducklings. Veterinary Microbiology, 228, 181–187.
  • Liu, X. & Kong, X. (2019). Isolation, identification and attenuation of a pathogenic duck hepatitis virus type 1 in China, and complete genomic sequence comparison between the embryo-passaged, attenuated derivatives and their parent. Polish Journal of Veterinary Sciences, 22, 163–171.
  • Mao, S., Ou, X., Wang, M., Sun, D., Yang, Q., Wu, Y., Jia, R., Zhu, D., Zhao, X., Chen, S., Liu, M., Zhang, S., Huang, J., Gao, Q., Liu, Y., Yu, Y., Zhang, L., Tian, B., Pan, L., Chen, X. & Cheng, A. (2021). Duck hepatitis A virus 1 has lymphoid tissue tropism altering the organic immune responses of mature ducks. Transboundary and Emerging Diseases, 68, 3588–3600.
  • Mao, S., Wang, M., Ou, X., Sun, D., Cheng, A., Zhu, D., Chen, S., Jia, R., Liu, M., Yang, Q., Wu, Y., Zhao, X. & Chen, X. (2017). Virologic and immunologic characteristics in mature ducks with acute duck hepatitis A virus 1 infection. Frontiers in Immunology, 8, 1574.
  • Marsian, J., Fox, H., Bahar, M.W., Kotecha, A., Fry, E.E., Stuart, D.I., Macadam, A.J., Rowlands, D.J. & Lomonossoff, G.P. (2017). Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nature Communications, 8, 245.
  • Niu, Y., Liu, B., Sun, C., Zhao, L. & Chen, H. (2020). Construction of the recombinant duck enteritis virus delivering capsid protein VP0 of the duck hepatitis A virus. Veterinary Microbiology, 249, 108837.
  • Niu, Y., Ma, H., Ding, Y., Li, Z., Sun, Y., Li, M. & Shi, Y. (2019). The pathogenicity of duck hepatitis A virus types 1 and 3 on ducklings. Poultry Science, 98, 6333–6339.
  • Ou, X., Wang, M., Mao, S., Cao, J., Cheng, A., Zhu, D., Chen, S., Jia, R., Liu, M., Yang, Q., Wu, Y., Zhao, X., Zhang, S., Liu, Y., Yu, Y., Zhang, L., Chen, X., Peppelenbosch, M.P. & Pan, Q. (2018). Incompatible translation drives a convergent evolution and viral attenuation during the development of live attenuated vaccine. Frontiers in Cellular and Infection Microbiology, 8, 249.
  • Pan, M., Yang, X., Du, J., Zhou, L., Ge, X., Guo, X., Liu, J. & Zhang, D. (2011). Recovery of duck hepatitis A virus 3 from a stable full-length infectious cDNA clone. Virus Research, 160, 439–443.
  • Roh, J.H. & Kang, M. (2018). Live attenuated duck hepatitis virus vaccine in breeder ducks: protective efficacy and kinetics of maternally derived antibodies. Veterinary Microbiology, 219, 107–112.
  • Rohaim, M.A., Naggar, R.F.E., AbdelSabour, M.A., Ahmed, B.A., Hamoud, M.M., Ahmed, K.A., Zahran, O.K. & Munir, M. (2021). Insights into the genetic evolution of duck hepatitis A virus in Egypt. Animals, 11, 2741.
  • Romanutti, C., Keller, L. & Zanetti, F.A. (2020). Current status of virus-vectored vaccines against pathogens that affect poultry. Vaccine, 38, 6990–7001.
  • Somasundaram, B., Chang, C., Fan, Y.Y., Lim, P.Y., Cardosa, J. & Lua, L. (2016). Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells. Methods, 95, 38–45.
  • Song, S., Li, P., Zhang, R., Chen, J., Lan, J., Lin, S., Guo, G., Xie, Z. & Jiang, S. (2019). Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses. Vaccine, 37, 4364–4369.
  • Sui, N., Zhang, R., Jiang, Y., Yu, H., Xu, G., Wang, J., Zhu, Y., Xie, Z., & Hu, J. (2022). Long noncoding RNA expression rofiles elucidate the potential roles of lncRNA- XR_003496198 in duck hepatitis A virus type 1 infection. Frontiers in Cellular and Infection Microbiology, 12, 858537.
  • Tauraso, N.M., Coghill, G.E. & Klutch, M.J. (1969). Properties of the attenuated vaccine strain of duck hepatitis virus. Avian Diseases, 13, 321–329.
  • Todd, D., Smyth, V.J., Ball, N.W., Donnelly, B.M., Wylie, M., Knowles, N.J. & Adair, B.M. (2009). Identification of chicken enterovirus-like viruses, duck hepatitis virus type 2 and duck hepatitis virus type 3 as astroviruses. Avian Pathology, 38, 21–29.
  • Toth, T.E. (1969). Studies of an agent causing mortality among ducklings immune to duck virus hepatitis. Avian Diseases, 13, 834–846.
  • Truong, T.N. & Cheng, L.T. (2022). Development of a subunit vaccine against duck hepatitis A virus serotype 3. Vaccines, 10, 523.
  • Tsai, H.-J. (2020). Duck hepatitis. In D.E. Swayne (Ed.), Diseases of poultry 14 ed. (pp. 450–460). Hoboken, NJ: Wiley-Blackwell.
  • Tseng, C.H., Knowles, N.J. & Tsai, H.J. (2007). Molecular analysis of duck hepatitis virus type 1 indicates that it should be assigned to a new genus. Virus Research, 123, 190–203.
  • Tseng, C.H. & Tsai, H.J. (2007). Molecular characterization of a new serotype of duck hepatitis virus. Virus Research, 126, 19–31.
  • Wang, A., Gu, L., Wu, S. & Zhu, S. (2018). Duck hepatitis A virus structural proteins expressed in insect cells self-assemble into virus-like particles with strong immunogenicity in ducklings. Veterinary Microbiology, 215, 23–28.
  • Wang, A.P., Liu, L., Gu, L.L., Guo, C.M., Wu, S., Feng, Q., Xia, W.L. & Zhu, S.Y. (2019). Protection against duck hepatitis A virus type 1 conferred by a recombinant avian adeno-associated virus. Poultry Science, 98, 112–118.
  • Wang, A.P., Liu, L., Gu, L.L., Wu, S., Guo, C.M., Feng, Q., Xia, W.L., Yuan, C. & Zhu, S.Y. (2019). Expression of duck hepatitis A virus type 1 VP3 protein mediated by avian adeno-associated virus and its immunogenicity in ducklings. Acta Virologica, 63, 53–59.
  • Wang, C., Li, X.K., Wu, T.C., Wang, Y., Zhang, C.J., Cheng, X.C. & Chen, P.Y. (2014). Recombinant VP1 protein of duck hepatitis virus 1 expressed in Pichia pastoris and its immunogenicity in ducks. Acta Virologica, 58, 333–339.
  • Wang, M., Chai, L., Liang, S., Lv, J., Yang, L., Qu, S., Jin, M., Li, Q. & Zhang, D. (2020). Fetal calf serum exerts an inhibitory effect on replication of duck hepatitis A virus genotype 1 in duck embryo fibroblast cells. Viruses, 12, 80.
  • Wang, M., Li, Z., Liu, H., Wang, X. & Zhang, D. (2019). Effect of fetal calf serum on propagation of duck hepatitis A virus genotype 3 in duck embryo fibroblast cells. BMC Veterinary Research, 15, 153.
  • Wang, W., Said, A., Wang, B., Qu, G., Xu, Q. & Liu, B. (2018). Establishment and evaluation of the goose embryo epithelial (GEE) cell line as a new model for propagation of avian viruses. PloS One, 13, e0193876.
  • Wen, X., Guo, J., Sun, D., Wang, M., Cao, D. & Cheng, A. (2019). Mutations in VP0 and 2C proteins of duck hepatitis A virus type 3 attenuate viral infection and virulence. Vaccines, 7, 111.
  • Wen, X., Zhu, D., Cheng, A., Wang, M., Chen, S., Jia, R., Liu, M., Sun, K., Zhao, X., Yang, Q. & Wu, Y. (2018). Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015. Transboundary and Emerging Diseases, 65, 10–15.
  • Woolcock, P.R. (1991). Duck hepatitis virus type I: studies with inactivated vaccines in breeder ducks. Avian Pathology, 20, 509–522.
  • Woolcock, P.R. & Crighton, G.W. (1979). Duck virus hepatitis: serial passage of attenuated virus in ducklings. The Veterinary Record, 105, 30–32.
  • Woolcock, P.R. & Crighton, G.W. (1981). Duck virus hepatitis: the effect of attenuation on virus stability in ducklings. Avian Pathology, 10, 113–119.
  • Wu, F., Lu, F., Fan, X., Chao, J., Liu, C., Pan, Q., Sun, H. & Zhang, X. (2020). Immune-related miRNA-mRNA regulation network in the livers of DHAV-3-infected ducklings. BMC Genomics, 21, 123.
  • Wu, F., Lu, F., Fan, X., Pan, Q., Zhao, S., Sun, H., Zhang, J., Liu, C., Chao, J. & Zhang, X. (2020). Development of a live attenuated duck hepatitis A virus type 3 vaccine (strain SD70). Vaccine, 38, 4695–4703.
  • Xie, J., Wang, M., Cheng, A., Zhao, X.X., Liu, M. & Zhu, D. (2019). DHAV-1 inhibits type I interferon signaling to assist viral adaption by increasing the expression of SOCS3. Frontiers in Immunology, 10, 731.
  • Xie, J., Wang, M., Cheng, A., Zhao, X.X., Liu, M., Zhu, D., Chen, S., Jia, R., Yang, Q., Wu, Y., Zhang, S., Yu, Y., Zhang, L., Sun, K. & Chen, X. (2018). Cytokine storms are primarily responsible for the rapid death of ducklings infected with duck hepatitis A virus type 1. Scientific Reports, 8, 6596.
  • Yang, F., Liu, P., Li, X., Liu, R., Gao, L., Cui, H., Zhang, Y., Qi, X., Pan, Q. & Wang, X. (2021). Recombinant duck enteritis virus-vectored bivalent vaccine effectively protects against duck hepatitis A virus infection in ducks. Frontiers in Microbiology, 12, 813010.
  • Yehia, N., Erfan, A.M., Omar, S.E. & Soliman, M.A. (2021). Dual circulation of duck hepatitis A virus genotypes 1 and 3 in Egypt. Avian Diseases, 65, 1–9.
  • Yin, F., Jing, L., Zhang, S., Yu, M., Zhang, W. & Fan, G. (2015). Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis. Chinese Journal of Biotechnology, 31, 1579–1588.
  • Yugo, D.M., Hauck, R., Shivaprasad, H.L. & Meng, X.J. (2016). Hepatitis virus infections in poultry. Avian Diseases, 60, 576–588.
  • Yun, T., Ni, Z., Liu, G.Q., Yu, B., Chen, L., Huang, J.G. & Zhang, Y.M. (2010). Generation of infectious and pathogenic duck hepatitis virus type 1 from cloned full-length cDNA. Virus Research, 147, 159–165.
  • Zell, R., Delwart, E., Gorbalenya, A.E., Hovi, T., King, A.M.Q., Knowles, N.J., Lindberg, A.M., Pallansch, M.A., Palmenberg, A.C., Reuter, G., Simmonds, P., Skern, T., Stanway, G. & Yamashita, T. (2017). ICTV virus taxonomy profile: picornaviridae. Journal of General Virology, 98, 2421–2422.
  • Zhang, R., Chen, J., Zhang, J., Yang, Y., Li, P., Lan, J., Xie, Z. & Jiang, S. (2018). Novel duck hepatitis A virus type 1 isolates from adult ducks showing egg drop syndrome. Veterinary Microbiology, 221, 33–37.
  • Zhang, R., Xia, L., Chen, J., Gong, Y., Zhang, L., Li, P., Liu, H., Xie, Z. & Jiang, S. (2017). Molecular epidemiology and genetic diversity of duck hepatitis A virus type 3 in Shandong province of China, 2012-2014. Acta Virologica, 61, 463–472.
  • Zhang, R., Yang, Y., Lan, J., Xie, Z., Zhang, X. & Jiang, S. (2021). Evidence of possible vertical transmission of duck hepatitis A virus type 1 in ducks. Transboundary and Emerging Diseases, 68, 267–275.
  • Zhang, X., Cao, C., Liu, Y., Qi, H., Zhang, W., Hao, C., Chen, H., Gao, M., Wang, J. & Ma, B. (2018). Comparative liver transcriptome analysis in ducklings infected with duck hepatitis A virus 3 (DHAV-3) at 12 and 48 hours post-infection through RNA-seq. Veterinary Research, 49, 52.
  • Zhang, X., Cao, C., Qu, Z., Zhang, W., Liu, Y., Qi, H., Hao, C., Gao, M., Wang, J. & Ma, B. (2018). Pathogenicity of duck hepatitis A virus type 3 and innate immune responses of the ducklings to virulent DHAV-3. Molecular Immunology, 95, 30–38.
  • Zhang, X., Jiang, S., Wu, J., Zhao, Q., Sun, Y., Kong, Y., Li, X., Yao, M. & Chai, T. (2009). An investigation of duck circovirus and co-infection in Cherry Valley ducks in Shandong Province, China. Veterinary Microbiology, 133, 252–256.
  • Zhang, X., Zhang, R., Wang, J., Sui, N., Xu, G., Yan, H., Zhu, Y., Xie, Z. & Jiang, S. (2021). Construction of recombinant Lactococcus lactis strain expressing VP1 fusion protein of duck hepatitis A virus type 1 and evaluation of its immune effect. Vaccines, 9, 1479.
  • Zhang, Y., Cao, Q., Wang, M., Jia, R., Chen, S., Zhu, D., Liu, M., Sun, K., Yang, Q., Wu, Y., Zhao, X. & Cheng, A. (2017). The 3D protein of duck hepatitis A virus type 1 binds to a viral genomic 3’ UTR and shows RNA-dependent RNA polymerase activity. Virus Genes, 53, 831–839.
  • Zhao, Y., Deng, B., Pan, X., Zhang, J., Zuo, X., Wang, J., Lv, F., Lu, Y. & Hou, J. (2022). Optimization of heat-resistance technology for a duck hepatitis lyophilized live vaccine. Vaccines, 10, 269.
  • Zheng, W.Q., Song, M.X., Li, J.L., Huang, B., Li, Y.F. & Yu, K.X. (2017). Generation and evaluation of recombinant Newcastle disease viruses (NDV) expressing VP1 gene of duck hepatitis A viruses (DHAV) type 1 and 3. Chinese Journal of Veterinary Science, 37, 1641-1647.
  • Zhu, T., Qi, B., Liu, R., Jiang, X., Lu, R., Xiao, L., Fu, G., Fu, Q., Shi, S., Wan, C. & Huang, Y. (2019). Comparative pathogenicity of two subtypes (hepatitis-type and pancreatitis-type) of duck hepatitis A virus type 1 in experimentally infected Muscovy ducklings. Avian Pathology, 48, 352–361.
  • Zou, Z., Ma, J., Huang, K., Chen, H., Liu, Z. & Jin, M. (2016). Live attenuated vaccine based on duck enteritis virus against duck hepatitis A virus types 1 and 3. Frontiers in Microbiology, 7, 1613.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.